News & Updates

Stay updated with our latest developments and industry news

1/15/2024
ELEM Biotech
Company
ELEM Biotech Completes Series B Funding
ELEM Biotech announces successful Series B funding round to accelerate platform development, expand production capacity, and enhance service offerings.
1/20/2024
Dr. James Liu
Technology
CRISPR-Cas9 Gene Editing: From Bench to Bedside
Explore how CRISPR-Cas9 technology is revolutionizing drug discovery and therapeutic development, from basic research to clinical applications.
2/10/2024
Dr. Sarah Chen
Industry
The Rise of Functional Genomics in Drug Discovery
Analyzing the growing role of functional genomics approaches in identifying and validating novel therapeutic targets for complex diseases.
2/20/2024
ELEM Biotech
Product
Introducing Harbor™ Targeted Integration Technology
ELEM Biotech launches revolutionary Harbor™ technology platform enabling rapid, efficient targeted gene integration for stable cell line development.
3/5/2024
Dr. Michael Rodriguez
Research
Advancing Cancer Immunotherapy: CRISPR Screens Identify Novel Checkpoint Targets
Recent CRISPR-based functional genomics studies reveal new immune checkpoint regulators, opening avenues for next-generation cancer immunotherapies.
3/15/2024
Dr. Sarah Chen
Technology
Best Practices for CRISPR Knockout Validation
Essential guidelines for validating CRISPR knockout experiments, ensuring reproducible results and avoiding common pitfalls in gene editing studies.
ELEM Biotech - 粒曼生物

Professional high-throughput gene editing solutions provider, dedicated to advancing drug discovery and fundamental research innovation.

Contact

Follow Us

© 2026 ELEM Biotech. All rights reserved.